IgG4-Related Disease Clinical Trials

Find IgG4-Related Disease Clinical Trials Near You

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

The goal of this observational study is to create a single macro registry system with data collection on common clinical features, grouping the different rare diseases (RD). Moreover, the specific goals are to generate an alert system for possible cases of RD with data from the electronic medical record, to describe the occurrence of RD in the evaluated population, to characterize the population, to describe patterns of diagnosis and treatment of RD present at the time, and to explore patient-reported outcomes.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Clinical and/or molecular diagnosis of any of the following rare diseases: Amyloidosis, Sarcoidosis, Phacomatosis, Pheochromocytoma, Paraganglioma, Von Hippel-Lindau Disease, Immunoglobulin G4-Related Disease, Demyelinating Diseases, Inborn Errors of Metabolism, Eosinophilic Gastrointestinal Disorders, Hypertrophic Cardiomyopathy, Gaucher Disease, Congenital Adrenal Hyperplasia, Hereditary Angioedema, Pulmonary Hypertension, Wilson Disease, Vascular Anomalies, Mastocytosis, Multiple Endocrine Neoplasia, Inflammatory Bowel Diseases, Prader-Willi Syndrome, Hirschsprung Disease, or Cushing Syndrome.

• Must be followed at Hospital Italiano de Buenos Aires.

Locations
Other Locations
Argentina
Hospital Italiano de Buenos Aires
RECRUITING
Buenos Aires
Hospital Italiano de Buenos Aires
RECRUITING
Buenos Aires
Hospital Italiano de Buenos Aires
RECRUITING
Buenos Aires
Contact Information
Primary
Maria Lourdes Posadas Martinez, PhD
maria.posadas@hospitalitaliano.org.ar
+54 11 49590200
Backup
Paula Scibona, MD
cepi@hospitalitaliano.org.ar
+54 11 49590200
Time Frame
Start Date: 2024-07-01
Estimated Completion Date: 2034-12-31
Participants
Target number of participants: 380
Related Therapeutic Areas
Sarcoidosis
Prader-Willi Syndrome
Pheochromocytoma
Movement Disorders
Ectodermal Dysplasias
Intersex
Neuroendocrine Tumor
IgG4-Related Disease
Pulmonary Hypertension
Cushing's syndrome
Hepatocerebral Degeneration
Hereditary Angioedema
Primary Amyloidosis
Multiple Endocrine Neoplasia
Von Hippel-Lindau (VHL) Syndrome
Hypertension
Congenital Adrenal Hyperplasia (CAH)
Cushing's disease
Mast Cell Activation Syndrome (MCAS)
Angioedema
Aplasia Cutis Congenita
Hives
Hirschsprung Disease
Cardiomyopathy
Hypertrophic Cardiomyopathy (HCM)
Wilson Disease
Clouston Syndrome
Viral Gastroenteritis
Gaucher Disease
Sponsors
Leads: Hospital Italiano de Buenos Aires

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

National Registry of IgG4-RD in China

National Registry of IgG4-RD in China

Enrollment Status: Recruiting
Publish Date: January 24, 2017

Exploratory Clinical Study of Anti-BCMA-CD19 CAR-T Cell Therapy for Relapsed/Refractory IgG4-Related Disease

Exploratory Clinical Study of Anti-BCMA-CD19 CAR-T Cell Therapy for Relapsed/Refractory IgG4-Related Disease

Enrollment Status: Recruiting
Publish Date: September 03, 2025
Intervention Type: Biological
Study Phase: Phase 2

A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-RD

A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-RD

Enrollment Status: Recruiting
Publish Date: July 16, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View All
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved